Wolff Wiese Magana LLC Increases Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wolff Wiese Magana LLC grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,194 shares of the medical equipment provider’s stock after purchasing an additional 49 shares during the period. Wolff Wiese Magana LLC’s holdings in Intuitive Surgical were worth $623,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth approximately $33,000. Mark Sheptoff Financial Planning LLC acquired a new stake in Intuitive Surgical in the second quarter valued at approximately $37,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the third quarter worth approximately $38,000. Finally, DT Investment Partners LLC grew its holdings in Intuitive Surgical by 80.0% during the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the business’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Up 3.6 %

Shares of Intuitive Surgical stock opened at $558.46 on Wednesday. The business’s fifty day moving average price is $537.05 and its 200 day moving average price is $496.50. Intuitive Surgical, Inc. has a twelve month low of $355.17 and a twelve month high of $559.94. The stock has a market capitalization of $198.91 billion, a P/E ratio of 89.78, a PEG ratio of 5.31 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of analyst reports. Leerink Partners boosted their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research note on Monday, October 14th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Royal Bank of Canada lifted their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.